Design and Synthesis of Novel 2‐Trifuoromethyl‐Quinazolin‐4‐Amine Derivatives as Potential <scp>WRN</scp>‐Dependent Anti‐Prostate Cancer Agents

Gang Yu(Sanya University), Jia Yu(Guiyang Medical University), Liang Qi(Zhejiang Lab), Xiaolin Peng(Guizhou University), Meng Mao(Guiyang Medical University), Bixue Xu(Guiyang Medical University), Heng Luo(Guiyang Medical University)
Journal of Heterocyclic Chemistry
July 15, 2025
10.1002/jhet.70032
Cited by 0

Related Papers

A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China
|The Lancet|2021|579
Burosumab Therapy in Children with X-Linked Hypophosphatemia
|New England Journal of Medicine|2018|479
Prevalence of Autism Spectrum Disorder in China: A Nationwide Multi-center Population-based Study Among Children Aged 6 to 12 Years
|Neuroscience Bulletin|2020|468
Olig2 Targets Chromatin Remodelers to Enhancers to Initiate Oligodendrocyte Differentiation
|Cell|2013|384
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
|The Lancet|2019|375